Please fill in the form below and an Ezra representative will contact you within 1 business day.
Please fill in the form below and we will be in touch when we launch in your city.
Of the 18.1 million people who will be diagnosed with cancer this year, half will be diagnosed late.1http://gco.iarc.fr/today/fact-sheets-cancers2https://seer.cancer.gov/ And here’s the really alarming news: patients who detect cancer late are much less likely to survive than those who find it early. We need to rethink the way we approach cancer screening.
”At Ezra, we believe checking your body for cancer should be part of your routine health regimen. To make that possible, we’re combining a better patient experience with the most advanced medical imaging and artificial intelligence to make cancer screening faster, more accurate, and more affordable for everyone.
That means providing consumers with convenient, MRI-based scans that are superior to traditional screening modalities; access to expert radiologists, who are assisted by the latest in Artificial Intelligence; and compassionate, ongoing support from our team of Ezra Guides. Let’s remove the stress, anxiety, and human error from the cancer screening process — and give people a better way to take proactive care of their health year after year.”
Together with the most prominent medical experts in the nation, we’ve designed proprietary MRI scanning protocols tailored to detect cancer anywhere in the body. Furthermore, every single Ezra scan is analyzed by multiple board-certified radiologists.
In addition to our board-certified radiologists, we’re also developing the Ezra AI — artificial intelligence technology designed to make radiologists more accurate and more productive. The Ezra AI is an investigational device that has not received marketing authorization from the FDA, thus the safety and effectiveness of the device have not yet been established. After further study of our AI technology, we plan to seek FDA clearance and make the Ezra AI available to radiologists.
We are backed by some of the most prominent investors in the world, committed to our long-term vision of detecting cancer early for everyone in the world.
Executive Founder at Wellville
Board Member at 23andme
CEO & co-founder of TransferWise
CEO & Founder of UiPath
Founder & CEO of Harvest Digital
Founder & CEO of SoundCloud
President at IT-FARM
Founder & CEO of Sourcepoint
CEO & co-founder of Eastnine
Chief Commercial Officer at Teads
Founder & CEO at Lateral
Co-founder & CTO at Liverail
Head of Product at Liverail